© iStock/OlegMalyshev Australia medical cannabis innovation company LeafCann has been granted official licences to research and cultivate medical cannabis. Along with the manufacturing licence LeafCann already holds, the company is now fully licensed by the Australian Office of Drug Control for all stages of the Australia medical cannabis supply chain; enabling it to make full use of its ‘seed to sale’ facilities. Elisabetta Faenza, CEO of LeafCann Group , said: “This is such an exciting moment for the whole organisation. The next 12 to 18 months are going to be extremely exciting as we roll out our detailed plans and turn these licences into a business that produces person-centred, precision medicines for Australian patients, creating exceptional value for our customers, staff and investors.” LeafCann, which aims to reintroduce plant-based medicines and nutritional products into the mainstream through a combination of research and development, commercial production and building strong partnerships […]